title: Mutant human torsinA, responsible for early-onset dystonia, dominantly suppresses GTPCH expression, dopamine levels and locomotion in Drosophila melanogaster.
abstract: Dystonia represents the third most common movement disorder in humans with over 20 genetic loci identified. TOR1A (DYT1), the gene responsible for the most common primary hereditary dystonia, encodes torsinA, an AAA ATPase family protein. Most cases of DYT1 dystonia are caused by a 3 bp (ΔGAG) deletion that results in the loss of a glutamic acid residue (ΔE302/303) in the carboxyl terminal region of torsinA. This torsinAΔE mutant protein has been speculated to act in a dominant-negative manner to decrease activity of wild type torsinA. Drosophila melanogaster has a single torsin-related gene, dtorsin. Null mutants of dtorsin exhibited locomotion defects in third instar larvae. Levels of dopamine and GTP cyclohydrolase (GTPCH) proteins were severely reduced in dtorsin-null brains. Further, the locomotion defect was rescued by the expression of human torsinA or feeding with dopamine. Here, we demonstrate that human torsinAΔE dominantly inhibited locomotion in larvae and adults when expressed in neurons using a pan-neuronal promoter Elav. Dopamine and tetrahydrobiopterin (BH4) levels were significantly reduced in larval brains and the expression level of GTPCH protein was severely impaired in adult and larval brains. When human torsinA and torsinAΔE were co-expressed in neurons in dtorsin-null larvae and adults, the locomotion rates and the expression levels of GTPCH protein were severely reduced. These results support the hypothesis that torsinAΔE inhibits wild type torsinA activity. Similarly, neuronal expression of a Drosophila DtorsinΔE equivalent mutation dominantly inhibited larval locomotion and GTPCH protein expression. These results indicate that both torsinAΔE and DtorsinΔE act in a dominant-negative manner. We also demonstrate that Dtorsin regulates GTPCH expression at the post-transcriptional level. This Drosophila model of DYT1 dystonia provides an important tool for studying the differences in the molecular function between the wild type and the mutant torsin proteins.
authors.affiliation: Department of Neurology, Massachusetts General Hospital and Program in Neuroscience, Harvard Medical School, Boston, MA 02129, USA.
authors.forename: Noriko
authors.initials: N
authors.lastname: Wakabayashi-Ito
authors.affiliation: Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA.
authors.forename: Rami R
authors.initials: RR
authors.lastname: Ajjuri
authors.affiliation: Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA.
authors.forename: Benjamin W
authors.initials: BW
authors.lastname: Henderson
authors.affiliation: Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA.
authors.forename: Olugbenga M
authors.initials: OM
authors.lastname: Doherty
authors.affiliation: Department of Neurology, Massachusetts General Hospital and Program in Neuroscience, Harvard Medical School, Boston, MA 02129, USA.
authors.forename: Xandra O
authors.initials: XO
authors.lastname: Breakefield
authors.affiliation: Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA.
authors.forename: Janis M
authors.initials: JM
authors.lastname: O'Donnell
authors.affiliation: Department of Neurology, Massachusetts General Hospital and Program in Neuroscience, Harvard Medical School, Boston, MA 02129, USA iton@helix.mgh.harvard.edu.
authors.forename: Naoto
authors.initials: N
authors.lastname: Ito
keywords: Drosophila; Dystonia; GTP cyclohydrolase; Movement disorder; TorsinA